Clinical Trials · NCT02313051
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Enrollment
- 200
- Start date
- Dec 2014
- Locations
- 1 site, China
- Primary endpoint
- Progression free survival